Kim, Sunnie <br/><br/>
Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States.  [electronic resource] 

 -  Advances in therapy  10 2018 
 - 1564-1577 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-018-0784-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Albumins--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cohort Studies<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Irinotecan--administration & dosage<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Oxaliplatin--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome<br/>United States--epidemiology<br/>Gemcitabine